Urszula Wojtyra moderates panel on biosimilar patent disputes for LSPN Connect
On Thursday, February 25, 2021, partner Urszula Wojtyra will moderate “Biosimilar Patent Disputes: What the Early Wave of Litigation Signals for the Future”, a virtual panel as part of LSPN Connect.
Since the formalisation of the new BPCIA framework in 2014, there has been a wave of patent infringement suits filed leading to a trend of innovator-versus-biosimilar disputes. The panel will explore the trends shown by these early suits, and the legal and strategic questions they raise. Discussion points will also include patent dance, patent thickets, viable strategies and the role that settlements play.
Joining Urszula in discussion are William Coppola of Aerie Pharmaceuticals, Professor Eva Kabir from the Department of Pharmacy at BRAC University and Irena Royzman of Kramer Levin Naftalis & Frankel LLP.
Webinar registration is available here: https://www.lspnconnect.com/agenda/session/458592
LSPN Connect is an exclusive online content and networking platform that connects a global community of life sciences professionals and IP experts, providing access to practical insights on the patent landscape around the world.
Smart & Biggar is widely recognized as Canada’s leading firm for intellectual property law, with offices in Ottawa, Toronto, Montreal, Vancouver and Calgary. We are leaders in intellectual property and technology law and have been serving clients for over a century.